01857nam 2200445 450 991069386990332120221024193048.0(CKB)3450000000002494(NjHacI)993450000000002494(OCoLC)55017158ocm55017158(OCoLC)993450000000002494(EXLCZ)99345000000000249420221024d2004 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierEffects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis /Catherine H. MacLean [and eleven others]Rockville (MD) :Agency for Healthcare Research and Quality (US),[2004]©20041 online resource (4 pages) illustrationsEvidence report/technology assessment. Summary ;no. 89AHRQ pub. ;no. 04-E012-1Title from title screen (viewed on Apr. 24, 2004).Includes bibliographical references.Omega-3 fatty acidsMeta-analysisOmega-3 fatty acids.Meta-analysis.612.397MacLean Catherine H.1351585United States.Agency for Healthcare Research and Quality.NjHacINjHaclBOOK9910693869903321Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis3121139UNINA